Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Luxury department store Saks Inc. (SKS - Analyst Report) has reported positive same-store sales and total sales for the month of May 2012, benefiting from the strong performance of women’s contemporary and "wear now" apparel.
Further, women’s shoes, fashion and fine jewelry, cosmetics and fragrances, men’s contemporary apparel, and men’s shoes all contributed to the decent sales results.
Saks’ comparable store sales increased 4.0% in May, with total sales for the four weeks ended May 26, 2012 climbing 3.7% to $215.8 million. The comparable sales growth for the month of May 2012 was within the mid-single digit guidance range for the second quarter.
For the four months ended May 26, 2012, sales climbed 4.1% year over year to $959.7 million compared with $921.8 million for the prior year four months ended May 28, 2011.
Saks’ peer Macy’s Inc. (M - Analyst Report) also performed well in the month of May. Macy’s total sales grew 4.1% to $2.0 billion for the four-week period ended May 26, 2012 compared with total sales of $1.9 billion for the month of May 2011. Same-store sales rose 4.2% year over year for the month.
Guidance
Saks projects same-store inventory levels to increase in the mid-single-digit range throughout fiscal 2012.
Saks has planned to invest in some operational initiatives and other strategies in the calendar year 2012 such as the project evolution systems implementation, hold and flow, and other local marketing business plans, which are expected to have a meaningful beneficial impact in the calendar year 2013 and beyond.
Further, the company intends to be very strategic in its SG&A spending, inventory management and capital expenditure. The company expects 30 to 50 basis points of SG&A expense deleverage in the second quarter and approximately 50 to 75 basis points in the second half of fiscal 2012.
The Zacks Consensus Estimate for the second quarter of 2012 is currently pegged at a loss of 8 cents.
However, we remain concerned with the ever-changing demands of the consumers, increased volatility in the financial markets and the overall uncertainty in the macroeconomic environment.
Currently, we have a long-term Neutral recommendation on Saks, which carries a Zacks #4 Rank (short-term Sell rating).
Get the full Analyst Report on SKS - FREE
Get the full Analyst Report on M - FREE